Kala Bio Inc (KALA)
6.82
+0.04
(+0.60%)
USD |
NASDAQ |
Nov 05, 11:21
Kala Bio 1 Year Total Returns (Daily): -3.15% for Nov. 4, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 04, 2024 | -3.15% |
November 01, 2024 | 1.56% |
October 31, 2024 | 2.03% |
October 30, 2024 | -1.01% |
October 29, 2024 | 5.42% |
October 28, 2024 | 5.43% |
October 25, 2024 | -7.80% |
October 24, 2024 | -13.07% |
October 23, 2024 | -20.39% |
October 22, 2024 | -24.86% |
October 21, 2024 | -28.80% |
October 18, 2024 | -32.29% |
October 17, 2024 | -36.26% |
October 16, 2024 | -34.25% |
October 15, 2024 | -36.35% |
October 14, 2024 | -36.72% |
October 11, 2024 | -37.64% |
October 10, 2024 | -39.19% |
October 09, 2024 | -38.82% |
October 08, 2024 | -40.07% |
October 07, 2024 | -39.62% |
October 04, 2024 | -36.02% |
October 03, 2024 | -39.91% |
October 02, 2024 | -39.84% |
October 01, 2024 | -38.43% |
Date | Value |
---|---|
September 30, 2024 | -35.96% |
September 27, 2024 | -40.29% |
September 26, 2024 | -44.80% |
September 25, 2024 | -44.62% |
September 24, 2024 | -46.64% |
September 23, 2024 | -45.09% |
September 20, 2024 | -45.68% |
September 19, 2024 | -46.05% |
September 18, 2024 | -45.59% |
September 17, 2024 | -45.91% |
September 16, 2024 | -45.81% |
September 13, 2024 | -47.00% |
September 12, 2024 | -47.81% |
September 11, 2024 | -46.77% |
September 10, 2024 | -46.61% |
September 09, 2024 | -46.25% |
September 06, 2024 | -49.66% |
September 05, 2024 | -49.91% |
September 04, 2024 | -54.43% |
September 03, 2024 | -55.41% |
August 30, 2024 | -56.67% |
August 29, 2024 | -56.47% |
August 28, 2024 | -55.90% |
August 27, 2024 | -55.44% |
August 26, 2024 | -54.93% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.32%
Minimum
Nov 08 2022
158.3%
Maximum
Jun 16 2020
-27.81%
Average
-50.27%
Median
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -58.62% |
AIM ImmunoTech Inc | -48.90% |
IGC Pharma Inc | 20.77% |
NovaBay Pharmaceuticals Inc | -93.97% |
Protalix BioTherapeutics Inc | -30.81% |